Study of 124,000 Siblings Clears Paracetamol Fears

Expecting mothers around the world can breathe easier today thanks to groundbreaking research that puts to rest worrying claims about a common pain reliever.

Scientists at the University of Hong Kong tracked 124,333 siblings over two decades and found zero evidence linking paracetamol use during pregnancy to autism or ADHD. The massive study compared siblings from the same family where mothers took the medication during one pregnancy but not another.

The research comes as welcome relief after public health officials worried that misleading statements in 2024 could dissuade pregnant women from treating pain and fever. Australia's Health Minister Mark Butler expressed concern that over 200,000 expecting mothers in Australia alone might feel afraid to treat illness.

"Pregnancy is a time when every decision can feel high-stakes, especially when the headlines are alarming," said Dr. Shan Luo, the study's co-author and mother herself. She hopes the findings help women "make decisions based on data rather than fear."

The study's brilliant design made it especially powerful. By comparing siblings from the same family, researchers controlled for genetics and socioeconomic factors that often muddy medical research. Hong Kong's comprehensive electronic health records allowed them to track mother-child pairs from 2001 to 2023 with remarkable detail.

About 43 percent of pregnancies in the study involved paracetamol prescriptions. The medication, called Tylenol in the United States, is classified as Category A in Australia, meaning it's considered safe during pregnancy.

Why This Inspires

This research represents science working exactly as it should. When fear-based claims threaten public health, researchers responded with the largest sibling study of its kind to provide clear answers.

The study's size and careful design mean the results are rock solid. Even accounting for limitations like over-the-counter purchases not captured in records, the overwhelming evidence points to safety.

Professor Peter Tanuseputro emphasized that untreated fever and pain carry their own risks during pregnancy. "Paracetamol should not be used unnecessarily, but it should not be avoided when it is clinically needed," he explained.

The research adds to mounting evidence that supports what medical professionals have long known. For the Australian Medical Association, which had warned against "anxiety, guilt and confusion" from misinformation, these findings provide ammunition to support patients.

Perhaps most importantly, the study reminds us that in an age of viral claims and social media health advice, rigorous science still wins. Over 124,000 families contributed data that will now help millions of mothers worldwide make informed choices without fear.

Women deserve to manage their health with confidence, and this research delivers exactly that.